analyzeportfolio
NYSE · Industrials

HERBALIFE LTD. (HLF)

As-reported financials and SEC filings for HERBALIFE LTD. The latest annual period is FY2025. The latest reported quarter is Q2 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About HERBALIFE LTD.

Herbalife Ltd. is a global health and wellness company that sells nutrition products through a direct-selling network of independent members. Its main products include weight management shakes, targeted nutrition supplements, energy and fitness products, and outer nutrition skincare items. The company serves consumers seeking to improve their health and wellness as well as distributors who resell products or build sales organizations in 95 markets worldwide.

Snapshot

Revenue
$5.04B
Revenue growth (YoY)
0.9%
Net income
$228.3M
Diluted EPS
$2.20
Gross margin
77.9%
Operating margin
9.5%
Net margin
4.5%
FCF margin
5.0%
ROE
net income / fiscal-year-end equity
P/E
8.3×
trailing when available, otherwise FY EPS
Market cap
$1.28B
Long-term debt / equity
non-current term debt only

Fundamentals are from SEC filings for FY2025, the latest annual period (ended December 31, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Herbalife

  • Revenue grew 0.9% to $5.0B in FY2025, after a 1.4% decline the year before.
  • Operating margin is 9.5% in FY2025, -3.1 pp against 12.7% in FY2021.
  • Most recent quarter Q2 FY2026: revenue $1.3B, up 5.4% from Q2 FY2025.
  • Free cash flow was $253M in FY2025, 5.0% of revenue.
  • Net income fell 10.2% to $228M in FY2025.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Herbalife’s fundamentals sit among the 684 Industrials companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Gross margin77.9%
98th percentile of 466
Operating margin9.5%
65th percentile of 605
Net margin4.5%
55th percentile of 645
FCF margin5.0%
51st percentile of 562
Revenue growth (YoY)+0.9%
37th percentile of 668
P/E8.3×
12th percentile of 434
Short interest5.05d
75th percentile of 676

Herbalife’s gross margin of 77.9% ranks in the 98th percentile of the 466 Industrials companies reporting it. Herbalife’s P/E of 8.3 ranks in the 12th percentile of the 434 peers with a meaningful P/E.

1 reported insider purchase (code P) totaling $13,572 in the last 90 days. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.

Buys (90d)
1
1 insider
Bought (90d)
$14K
code P value
Sells (90d)
0
Reported activity
Net buying
by $ value, 90d
Trade dateInsiderTypeSharesPriceValue
2026-06-04
L'Helias SophieDirectorBuy1.2K$11.31$14K
2026-05-19
filed 2026-05-20
Hicks TroyChief Operating OfficerSell10.0K$12.32$123K
2026-05-18
filed 2026-05-20
Hicks TroyChief Operating OfficerSell38.4K$12.93$496K
2026-05-12
Lamberti FrankChief Commercial OfficerSell135.0K$13.50$1.8M
2026-05-11
filed 2026-05-12
Lamberti FrankChief Commercial OfficerSell7.9K$13.86$110K

Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
9.3M
settled 2026-08-14
Change vs prior
+2.5%
vs previous settlement
Days to cover
5.05
at avg daily volume
Avg daily volume
1.8M
FINRA reported
SettlementShares shortChangeDays to cover
2026-08-149.3M+2.5%5.05
2026-07-319.1M-2.6%7.90
2026-07-159.3M+8.2%5.62
2026-06-308.6M+8.5%4.18
2026-06-157.9M+8.0%4.98
2026-05-297.3M-6.8%5.04
2026-05-157.9M-5.5%4.57
2026-04-308.3M+0.0%8.78

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022FY2021
Revenue$5.04B$4.99B$5.06B$5.20B$5.80B
Gross profit$3.92B$3.89B$3.87B$4.03B$4.56B
Operating income$481.0M$385.9M$356.4M$545.2M$734.1M
Net income$228.3M$254.3M$142.2M$321.3M$447.2M
Diluted EPS$2.20$2.50$1.42$3.23$4.13

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Balance sheet (as reported)

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022FY2021
Operating cash flow$333.3M$285.4M$357.5M$352.5M$460.3M
Capital expenditure$80.4M$122.0M$135.0M$156.4M$151.4M
Free cash flow$252.9M$163.4M$222.5M$196.1M$308.9M

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q2 FY2026$1.33B5.4%$-26.3M$-0.25
Q1 FY2026$1.32B7.8%$61.9M$0.57
Q4 FY2025$1.28B6.3%$85.4M$0.82
Q3 FY2025$1.27B2.7%$43.2M$0.42
Q2 FY2025$1.26B-1.7%$49.3M$0.48
Q1 FY2025$1.22B-3.4%$50.4M$0.49
Q4 FY2024$1.21B-0.6%$177.9M$1.74
Q3 FY2024$1.24B-3.2%$47.4M$0.46

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeNYSE
SectorIndustrials
SIC industryWholesale-Drugs, Proprietaries & Druggists' Sundries
Latest annual periodFY2025 (ended December 31, 2025)
Latest reported quarterQ2 FY2026 (ended June 30, 2026)
Oldest indexed filing2015
SEC CIK1180262

Selected SEC filings

10-Q2026-08-05
View on EDGAR →
10-Q2026-05-06
View on EDGAR →
8-K2026-08-31
View on EDGAR →
8-K2026-08-05
View on EDGAR →
8-K2026-05-06
View on EDGAR →
8-K2026-05-01
View on EDGAR →

Largest Industrials peers

All Industrials companies →

Monitor HLF

Get an alert when Herbalife files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor HLF free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.